Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies

Neurotrophins: Roles in Neuronal Development and Function

Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · see citing works

Neurotrophin-regulated signalling pathways

Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195 · see citing works

TrkB signalling pathways in LTP and learning

Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055 · see citing works

Brain-derived neurotrophic factor in neurodegenerative diseases

Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · see citing works

Mechanism of TrkB-Mediated Hippocampal Long-Term Potentiation

Minichiello, L., Calella, A. M., Medina, D. L., Bonhoeffer, T., Klein, R., & Korte, M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00942-x · Cited by 506 · see citing works

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494 · see citing works

BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies

Ferrer, I., Marı́n, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E. S., & Martı́, E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00007 · Cited by 407 · see citing works

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats

Arancibia, S., Silhol, M., Mouliere, F. C., Meffre, J., Höllinger, I., Maurice, T., & Tapia‐Arancibia, L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.012 · Cited by 318 · see citing works

Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Yu, S. P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 289 · see citing works

Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

Ginsberg, S. D., Che, S., Wuu, J., Counts, S., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03764.x · Cited by 253 · see citing works

Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease

Yuede, C. M., Zimmerman, S., Dong, H., Kling, M. J., Bero, A. W., Holtzman, D. M., Timson, B. F., & Csernansky, J. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.002 · Cited by 250 · see citing works

Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease

Peng, S., Garzon, D. J., Marchese, M., Klein, W. L., Ginsberg, S. D., Francis, B. M., Mount, H. T. J., Mufson, E. J., Salehi, A., & Fahnestock, M. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4736-08.2009 · Cited by 216 · see citing works

Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease

Zhang, Z., Kang, S. S., Liu, X., Ahn, E. H., Zhang, Z., He, L., Iuvone, P. M., Duong, D. M., Seyfried, N. T., Benskey, M. J., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3433 · Cited by 198 · see citing works

Multistep Autoactivation of Asparaginyl Endopeptidase in Vitro and in Vivo

Li, D. N., Matthews, S. P., Antoniou, A. N., Mazzeo, D., & Watts, C. K. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305930200 · Cited by 184 · see citing works

Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells

Garzon, D. J., & Fahnestock, M. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5053-06.2007 · Cited by 182 · see citing works

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease

Murer, M. G., Boissière‐Michot, F., Yan, Q., Hunot, S., Villares, J., Faucheux, B. A., Agid, Y., Hirsch, É. C., & Raisman‐Vozari, R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00219-x · Cited by 176 · see citing works

NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons

Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806133105 · Cited by 169 · see citing works

A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex

Garzon, D. J., Yu, G., & Fahnestock, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01030.x · Cited by 152 · see citing works

Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease

Zhang, Z., Obianyo, O., Dall, E., Du, Y., Fu, H., Liu, X., Kang, S. S., Song, M., Yu, S.-P., Cabrele, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14740 · Cited by 146 · see citing works

C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease

Wang, Z.-H., Gong, K. Q., Liu, X., Zhang, Z., Sun, X., Wei, Z. Z., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Johnson, P. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04120-z · Cited by 140 · see citing works

CREB expression mediates amyloid β-induced basal BDNF downregulation

Rosa, E., & Fahnestock, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.014 · Cited by 138 · see citing works

Neuroprotective Actions of PIKE-L by Inhibition of SET Proteolytic Degradation by Asparagine Endopeptidase

Liu, Z., Jang, S., Liu, X., Cheng, D., Peng, J., Yepes, M., Li, X., Matthews, S., Watts, C. K. W., Asano, M., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.017 · Cited by 133 · see citing works

Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression

Rohe, M., Synowitz, M., Glaß, R., Paul, S. M., Nykjær, A., & Willnow, T. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3960-09.2009 · Cited by 122 · see citing works

Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage

Sabri, M., Ai, J., Lakovic, K., D’Abbondanza, J. A., Ilodigwe, D., & Macdonald, R. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.002 · Cited by 121 · see citing works

Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

Ando, S., Kobayashi, S., Waki, H., Kon, K., Fukui, F., Tadenuma, T., Iwamoto, M., Takeda, Y., Izumiyama, N., Watanabe, K., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10443 · Cited by 110 · see citing works

β-Amyloid (Aβ) Oligomers Impair Brain-derived Neurotrophic Factor Retrograde Trafficking by Down-regulating Ubiquitin C-terminal Hydrolase, UCH-L1

Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K., Zograbyan, V., Yaopruke, T., Shelanski, M. L., & Cotman, C. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463711 · Cited by 100 · see citing works

Neurotrophins Enhance CaMKII Activity and Rescue Amyloid-β-Induced Deficits in Hippocampal Synaptic Plasticity

Zeng, Y., Zhao, D., & Xie, C.-W. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100264 · Cited by 93 · see citing works

TrkB reduction exacerbates Alzheimer’s disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice

Devi, L., & Ohno, M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.55 · Cited by 92 · see citing works

Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease

Rosa, E., Mahendram, S., Ke, Y. D., Ittner, L. M., Ginsberg, S. D., & Fahnestock, M. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.020 · Cited by 91 · see citing works

Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy

Mazzaro, N., Barini, E., Spillantini, M. G., Goedert, M., Medini, P., & Gasparini, L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-15.2016 · Cited by 85 · see citing works

BDNF-, IGF-1- and GDNF-Secreting Human Neural Progenitor Cells Rescue Amyloid β-Induced Toxicity in Cultured Rat Septal Neurons

Kitiyanant, N., Kitiyanant, Y., Svendsen, C. N., & Thangnipon, W. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0592-1 · Cited by 76 · see citing works

BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation

Criscuolo, C., Fabiani, C., Bonadonna, C., Origlia, N., & Domenici, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.016 · Cited by 67 · see citing works

Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer’s Disease

Wang, Z.-H., Liu, P., Liu, X., Manfredsson, F. P., Sandoval, I. M., Yu, S. P., Wang, J., & Ye, K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.018 · Cited by 64 · see citing works

Oligomeric Amyloid-β Inhibits the Proteolytic Conversion of Brain-derived Neurotrophic Factor (BDNF), AMPA Receptor Trafficking, and Classical Conditioning*

Zheng, Z.-Q., Sabirzhanov, B., & Keifer, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150821 · Cited by 61 · see citing works

BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT

Wang, Z.-H., Wu, W., Kang, S. S., Liu, X., Wu, Z., Peng, J., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Liu, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99007 · Cited by 52 · see citing works

Brain derived neurotrophic factor induces a rapid upregulation of synaptophysin and tau proteins via the neurotrophin receptor TrkB in rat cerebellar granule cells

Coffey, E. T., Åkerman, K. E. O., & Courtney, M. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00335-2 · Cited by 48 · see citing works

Increased pro–nerve growth factor and decreased brain-derived neurotrophic factor in non–Alzheimer's disease tauopathies

Belrose, J. C., Masoudi, R., Michalski, B., & Fahnestock, M. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.029 · Cited by 43 · see citing works

Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter Aβ or Tau Pathology

Castello, N. A., Green, K. N., & LaFerla, F. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039566 · Cited by 36 · see citing works

Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons

Atasoy, İ. L., Dursun, E., Gezen‐Ak, D., Armagan, D. M., Öztürk, M., & Yılmazer, S. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.11.007 · Cited by 31 · see citing works

The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro

Chen, Q., Zhou, Z., Zhang, L., Xu, S., Chen, C., & Yu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091793 · Cited by 25 · see citing works

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138 · see citing works

Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential

Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606 · see citing works

FSH blockade improves cognition in mice with Alzheimer’s disease

Xiong, J., Kang, S. S., Wang, Z., Liu, X., Kuo, T.-C., Korkmaz, F., Padilla, A., Miyashita, S., Chan, P., Zhang, Z., et al. (2022) · Nature · doi:10.1038/s41586-022-04463-0 · Cited by 329 · see citing works

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review

Jeremic, D., Jiménez-Díaz, L., & Navarro-López, J. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101496 · Cited by 306 · see citing works

New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease

Wu, J., Yu, Y., Wan, Y., Xia, J., Xu, J., Zhang, L., Liu, D., Chen, L., Tang, F., Ao, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113207 · Cited by 115 · see citing works

Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer’s disease pathology

Wu, Z., Wang, Z.-H., Liu, X., Zhang, Z., Gu, X., Yu, S. P., Keene, C. D., Cheng, L., & Ye, K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101730 · Cited by 81 · see citing works

Can exercise training teach us how to treat Alzheimer's disease?

Huuha, A. M., Norevik, C. S., Moreira, J. B. N., Kobro-Flatmoen, A., Scrimgeour, N., Kivipelto, M., Van Praag, H., Ziaei, M., Sando, S. B., Wisløff, U., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101559 · Cited by 79 · see citing works

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Zhang, Z., Tian, Y., & Ye, K. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0179-3 · Cited by 81 · see citing works

Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action

Hole, K. L., & Williams, R. J. (2020) · Brain Plasticity · doi:10.3233/bpl-200098 · Cited by 78 · see citing works

A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

Gadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 70 · see citing works

Tau Toxicity in Neurodegeneration

Liang, S., Wang, Z.-T., Tan, L., & Yu, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02809-3 · Cited by 58 · see citing works

BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT

Wang, Z.-H., Wu, W., Kang, S. S., Liu, X., Wu, Z., Peng, J., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Liu, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99007 · Cited by 52 · see citing works

Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease

Liao, J., Chen, C., Ahn, E. H., Liu, X., Li, H., Edgington‐Mitchell, L. E., Lu, Z., Ming, S., & Ye, K. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108737 · Cited by 50 · see citing works

A TrkB agonist prodrug prevents bone loss via inhibiting asparagine endopeptidase and increasing osteoprotegerin

Xiong, J., Liao, J., Liu, X., Zhang, Z., Adams, J., Pacifici, R., & Ye, K. (2022) · Nature Communications · doi:10.1038/s41467-022-32435-5 · Cited by 46 · see citing works

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease

Kang, S. S., Ahn, E. H., & Ye, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00494-7 · Cited by 45 · see citing works

Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer’s disease pathologies

Chen, G., Kang, S. S., Wang, Z., Ahn, E. H., Xia, Y., Liu, X., Sandoval, I. M., Manfredsson, F. P., Zhang, Z., & Ye, K. (2021) · Science Advances · doi:10.1126/sciadv.abe4499 · Cited by 44 · see citing works

TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies

Xia, Y., Wang, Z.-H., Liu, P., Edgington‐Mitchell, L. E., Liu, X., Wang, X., & Ye, K. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00863-8 · Cited by 42 · see citing works

Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity via Activation of TRKB Signaling in ΔK280 TauRD-DsRed SH-SY5Y Cells

Chiang, N.-N., Lin, T., Teng, Y.-S., Sun, Y., Chang, K., Lin, C., Hsieh‐Li, H. M., Su, M., Chen, C., & Lee‐Chen, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.758895 · Cited by 41 · see citing works

Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease

Salašová, A., Monti, G., Andersen, O. M., & Nykjær, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00576-2 · Cited by 35 · see citing works

C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis

Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37 · see citing works

Neuroprotective brain-derived neurotrophic factor signaling in the TAU-P301L tauopathy zebrafish model

Barbereau, C., Yehya, A., Silhol, M., Cubedo, N., Verdier, J., Maurice, T., & Rossel, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104865 · Cited by 33 · see citing works

Bridging neurotrophic factors and bioactive peptides to Alzheimer’s disease

Wei, M., Wu, T., & Chen, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102177 · Cited by 31 · see citing works

Psilocybin for the treatment of Alzheimer’s disease

Zheng, S., Ma, R., Yang, Y., & Li, G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420601 · Cited by 27 · see citing works

Local TrkB signaling: themes in development and neural plasticity

Johnstone, A. D., & Mobley, W. C. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03278-7 · Cited by 27 · see citing works

Harnessing BDNF Signaling to Promote Resilience in Aging

Faraji, J., & Metz, G. A. S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0961 · Cited by 28 · see citing works

Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review

Wang, D., Lang, Z., Wei, S., Wang, W., & Zhang, H. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.43 · Cited by 24 · see citing works

Alzheimer‐like tau accumulation in dentate gyrus mossy cells induces spatial cognitive deficits by disrupting multiple memory‐related signaling and inhibiting local neural circuit

Li, S., Zhou, Q., Liu, E., Du, H., Yu, N., Yu, H., Wang, W., Li, M., Weng, Y., Gao, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13600 · Cited by 23 · see citing works

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Wang, J., Hu, H., Liu, Z., Liu, J., Wang, S., Cheng, Q., Chen, H., & Song, M. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00235-4 · Cited by 22 · see citing works

The Peptide Ligase Activity of Human Legumain Depends on Fold Stabilization and Balanced Substrate Affinities

Dall, E., Stanojlović, V., Demir, F., Briza, P., Dahms, S. O., Huesgen, P. F., Cabrele, C., & Brandstetter, H. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c02057 · Cited by 22 · see citing works

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer’s disease in mice

Qian, Z., Li, B.-W., Meng, X., Liao, J., Wang, G., Li, Y., Luo, Q., & Ye, K.-Q. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01774-2 · Cited by 19 · see citing works

Target Enzymes Considered for the Treatment of Alzheimer’s Disease and Parkinson’s Disease

Kim, N., & Lee, H. J. (2020) · BioMed Research International · doi:10.1155/2020/2010728 · Cited by 21 · see citing works

Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis

Deng, C., & Chen, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106377 · Cited by 18 · see citing works

Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators

Jakaria, M., Belaidi, A. A., Southon, A. G., Dent, K. A., Lane, D. J. R., Bush, A. I., & Ayton, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416205 · Cited by 17 · see citing works

TrkB-Induced Inhibition of R-SMAD/SMAD4 Activation is Essential for TGF-β-Mediated Tumor Suppressor Activity

Kim, M. S., & Jin, W. (2020) · Cancers · doi:10.3390/cancers12041048 · Cited by 16 · see citing works

TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma

Kim, M. S., Lee, W. S., & Jin, W. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04960-z · Cited by 12 · see citing works

Legumain-induced intracerebrally crosslinked vesicles for suppressing efflux transport of Alzheimer's disease multi-drug nanosystem

Jiang, F., Ren, J., Gao, Y., Wang, J., Zhao, Y., & Dai, F. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.024 · Cited by 11 · see citing works

Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease

Wang, S., Liu, Z., Liu, J., Cheng, Q., Wang, Y., Liu, Y., Ni, W.-W., Chen, H., & Song, M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00988-0 · Cited by 11 · see citing works

PLCβ4 driven by cadmium-exposure during gestation and lactation contributes to cognitive deficits by suppressing PIP2/PLCγ1/CREB/BDNF signaling pathway in male offspring

Wang, Y., Peng, D., Zhang, X., Chen, J., Feng, J., Zhang, R., Mai, W., Chen, H., Yang, Y., Huang, Y., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134756 · Cited by 10 · see citing works

Cerebral Apolipoprotein D Exits the Brain and Accumulates in Peripheral Tissues

Desmarais, F., Hervé, V., Bergeron, K., Ravaut, G., Perrotte, M., Fyfe-Desmarais, G., Rassart, É., Ramassamy, C., & Mounier, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084118 · Cited by 9 · see citing works

STAT3 ameliorates truncated tau-induced cognitive deficits

Zhang, B., Wan, H., Maierwufu, M., Liu, Q., Li, T., He, Y., Wang, X., Liu, G., Hong, X., & Feng, Q. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382253 · Cited by 8 · see citing works

A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer’s disease mouse models through attenuating mitochondrial function

Wang, Y., Wang, J., Chen, H., Li, X., Xu, R., Gao, F., Yu, H., Li, F., Qin, D., Wang, J., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1293164 · Cited by 8 · see citing works

BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer’s disease

Thomson, D., Rosenich, E., Maruff, P. T., Lim, Y. Y., & Initiative, A. D. N. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae014 · Cited by 7 · see citing works

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition

Xiang, J., Qian, Z., Ye, X., Wei, Y., Wang, G., Liu, X., Wang, Z.-H., Zhang, Z., Wu, S., & Ye, K. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00854-9 · Cited by 6 · see citing works

In Silico Analysis to Link Insulin Resistance, Obesity and Ageing with Alzheimer’s Disease

Sarkar, P. A., Jayaraj, P., Patwardhan, K., Yeole, S., Das, S., Somaiya, Y., Desikan, R., & Thirumurugan, K. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01875-x · Cited by 5 · see citing works

Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase

Calugi, L., Lenci, E., Bianchini, F., Contini, A., & Trabocchi, A. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116746 · Cited by 5 · see citing works

Research progress on the role of acupuncture in Alzheimer's disease based on the PI3K/AKT/mTOR signaling pathway

Zhang, S., Gu, X. F., Zhang, M., Ding, N., Yang, J., & Wang, T. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418553 · Cited by 4 · see citing works

Disruption of BDNF signalling in neuropathologies

Paulo-Ramos, A., Rhymes, E. R., Villarroel‐Campos, D., & Sleigh, J. N. (2026) · Biochemical Society Transactions · doi:10.1042/bst20253079 · Cited by 3 · see citing works

Brain-Derived Neurotrophic Factor Potentiates Entorhinal-Dentate but not Hippocampus CA1 Pathway in Adult Male Rats: A Mechanism of Taurine-Modulated BDNF on Learning and Memory

Roysommuti, S., & Wyss, J. M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-93337-1_35 · Cited by 3 · see citing works

Legumain Functions as a Transient TrkB Sheddase

Holzner, C., Böttinger, K., Blöchl, C., Huber, C. G., Dahms, S. O., Dall, E., & Brandstetter, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065394 · Cited by 3 · see citing works

The role of TrkB receptor signaling in Alzheimer’s disease

He, K., Nie, L., Dai, Z., Li, S., Yang, X., & Liu, G. (2023) · Human Brain · doi:10.37819/hb.4.1788 · Cited by 2 · see citing works

BIN1 Interacts with Tau Fragments to Inhibit TrkB Signaling Endosome Recycling in a Mouse Model of Alzheimer’s Disease

Wei, Y., Ye, X., Li, H., Zhang, X., Wang, Y., Li, Y., Fang, R., Xiang, J., & Wu, S. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01435-y · Cited by 2 · see citing works

Aluminium, lead and manganese mixture exacerbates oxidative stress, neuroinflammation and apoptosis via downregulation of Nrf-2/HO-1/BDNF signalling pathway in rats

Dooka, B. D., Orish, C. N., Ezejiofor, A. N., Anyachor, C. P., Umeji, T. C., Nkpaa, K. W., Obasi, C. N., Ćirović, A., Ćirović, A., & Orisakwe, O. E. (2025) · Biomarkers · doi:10.1080/1354750x.2025.2522102 · Cited by 2 · see citing works

Mechanistic insights into cannabidiol-mediated TrkB activation via FRS2 interaction in attenuating Alzheimer’s disease pathology and cognitive impairment

Liu, J., Peng, F., Li, P., Yao, C., Jin, S., Wu, G., Zhang, T., Liang, Q., Wang, X., & Du, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03525-3 · Cited by 2 · see citing works

Decoding the secretase puzzle in amyloid-β generation: A state-of-the-art overview of the protease-mediated APP processing cascade in Alzheimer’s disease

Senkowska, Z., & Węglarz‐Tomczak, E. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103116 · Cited by 2 · see citing works

A Combined Computational and Experimental Approach to Studying Tropomyosin Kinase Receptor B Binders for Potential Treatment of Neurodegenerative Diseases

Nguyen, D. D., Mansur, S., Ciesla, L. M., Gray, N. E., Zhao, S., & Bao, Y. (2024) · Molecules · doi:10.3390/molecules29173992 · Cited by 2 · see citing works

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Arituluk, Z. C., Adhikari, B., Maitra, U., Goodman, C., & Ciesla, L. M. (2022) · Journal of Visualized Experiments · doi:10.3791/63118

Finding Memo: Versatile interactions of the VPS10p receptors in Alzheimer’s diseasePreprint

Salašová, A., Monti, G., Andersen, O. M., & Nykjær, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1650985/v1

Delta Secretase and BDNF Signalling in Alzheimer’s Disease

Ünlü, B., Ildız, S., Gezen‐Ak, D., & Dursun, E. (2023) · Experimed · doi:10.26650/experimed.1231893

BDNF Val66Met moderates increases in CSF t-tau and p-tau181 in early sporadic Alzheimer’s disease: A prospective cohort studyPreprint

Thomson, D., Rosenich, E., Maruff, P. T., & Lim, Y. Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3329091/v1

Conformational and Functional Regulation of SET by Legumain Cleavage

Horak, C., Wieland, A. C., Klaushofer, R., Briza, P., Brandstetter, H., & Dall, E. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169119

Positional scanning and computational modeling reveal determinants of legumain transpeptidase activity

Klaushofer, R., Dahms, S. O., Brandstetter, H., & Dall, E. (2026) · Protein Science · doi:10.1002/pro.70563

Additional file 1 of Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease

Wang, S.-S., Liu, Z.-K., Liu, J.-J., Cheng, Q., Wang, Y.-X., Liu, Y., Ni, W.-W., Hongzhuan, C. H. E. N., & Song, M. (2021) · Figshare · doi:10.6084/m9.figshare.15569164

Effects and mechanisms of amino acids in Alzheimer's disease: A narrative review

Yuliani, S., Annura, R., Lolita, L., Utami, D., & Amukti, D. P. (2026) · Scripta Medica · doi:10.5937/scriptamed57-58653

Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies

Barbereau, C. (2020) · theses.fr (ABES) · doi:10.70675/dfe1802ez70f2z4da6zb3e5z63d1de7a429c

Targeting the pathological tau N368 fragment: A pharmacological perspective on a novel immunotherapy for Alzheimer’s disease

Qian, Z., Hu, Z., Li, Y. C., Zuo, D., He, R., & Ye, K. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108337

BindingDB Entry 50017218: Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase.

BindingDB (2023) · UC San Diego · doi:10.7270/q2qz2g1s

Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases

Sun, J., Gao, G., Wang, S., Li, S., Tang, J., Liu, H., & Tang, T.-S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02776-4

Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease

Wang, Z.-H., Xiang, J., Liu, X., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Wu, S., Wang, J.-Z., & Ye, K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.054 · Cited by 238 · see citing works

P1‐190: DEFICIENCY IN BDNF/TRKB NEUROTROPHIC ACTIVITY STIMULATES DELTA‐SECRETASE VIA UPREGULATING C/EBPβ IN ALZHEIMER'S DISEASE

Wang, Z., Wang, J., & Ye, K. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.745

TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies

Xia, Y., Wang, Z.-H., Liu, P., Edgington‐Mitchell, L. E., Liu, X., Wang, X., & Ye, K. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00863-8 · Cited by 42 · see citing works

Delta Secretase and BDNF Signalling in Alzheimer’s Disease

Ünlü, B., Ildız, S., Gezen‐Ak, D., & Dursun, E. (2023) · Experimed · doi:10.26650/experimed.1231893

Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer’s disease

Wang, H., Liu, X., Chen, S., & Ye, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815915115 · Cited by 32 · see citing works